FOXO1 inactivation induces cisplatin resistance in bladder cancer

We found that FOXO1‐shRNA sublines or FOXO1‐positive cells co–treated with a FOXO1 inhibitor were significantly more resistant to cisplatin treatment at pharmacological concentrations, compared with respective control sublines or those with mock treatment. Western blot demonstrated considerable incr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Sci
Asıl Yazarlar: Ide, Hiroki, Goto, Takuro, Teramoto, Yuki, Mizushima, Taichi, Jiang, Guiyang, Nagata, Yujiro, Inoue, Satoshi, Baras, Alexander S., Kashiwagi, Eiji, Miyamoto, Hiroshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Letters to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469822/
https://ncbi.nlm.nih.gov/pubmed/32678492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14557
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller